Publish date:

Valeant Shares Pop After Halloween Selloff

Shares of the Canadian drugmaker were climbing in morning trading.

Shares of Valeant Pharmaceuticals (VRX) were up Tuesday as investors spotted what appears to be a discount following yesterday's steep selloff. Shares of the Canadian drugmaker had tanked 19% over the past two trading days amid concerns over industry-wide pricing cuts and news federal prosecutors are targeting Valeant in an investigation over accounting fraud. Valeant's real problem, as Real Money's Jim Cramer noted in a Tuesday investment note, is that Valeant may not be able to afford to cut prices on key drugs ahead of earnings next week.

Employees of TheStreet are restricted from owning individual securities.

TheStreet Recommends